ISSCA Brings Its International Regenerative Medicine Congress to Buenos Aires, Endorsed by the University of Buenos Aires
Two-day congress on July 10–11, 2026 convenes 20 international faculty and debuts ISSCA Panels, a live faculty debate format, alongside two advanced physician certifications.
BUENOS AIRES, Argentina — July 2, 2026 — The International Society for Stem Cell Application (ISSCA), the academic institution behind one of the world’s most active regenerative medicine congress circuits, will hold ISSCA 124 at the Hilton Buenos Aires on July 10–11, 2026. The congress is endorsed by the University of Buenos Aires (UBA), situating ISSCA’s clinical education within a recognized academic framework.
ISSCA 124 pairs a full scientific conference with two credentials for physicians: the Advanced Certification in Regenerative Medicine and the Advanced Certification in Peptides. The program convenes 20 international faculty from the United States, Argentina, Brazil, Mexico, Bolivia, and Portugal.
As the academic institution that runs the most regenerative medicine congresses in the world — 8 across Latin America and Europe in 2026 alone — and with more than 10,000 physicians certified across 30+ countries over 16 years, ISSCA positions Buenos Aires as the most global, most international, and most academic congress in the field.
The Buenos Aires edition introduces ISSCA Panels, a format that seats the assembled faculty together to debate clinical questions live before the audience, and features a live recording of Dr. Greg Jones’s podcast from the congress floor. Both extend ISSCA’s standard congress experience, which includes MedConnect medical networking, a Speakers’ Dinner, a live Q&A panel, and access to ISSCA AI and the ISSCA App.
ISSCA 124 is the twelfth congress in a 2026 circuit that has spanned Latin America and Europe, from Cartagena and Cancún to Lisbon, São Paulo, Punta Cana, and Lima. Founded in 2010, ISSCA has certified more than 10,000 physicians across 30+ countries over 16 years.
The congress follows ISSCA 123 in Lima, where the certification reached a historical attendance record, and precedes ISSCA’s Global Summit 125 in Cancún (September 25–27, 2026).
“Buenos Aires reflects what ISSCA has become: the most global and most academic regenerative medicine congress in the world, and the place where the best physicians choose to certify. The University of Buenos Aires endorsement puts a recognized academic framework behind education physicians can apply the day they return to practice.” — Emiliano Herrera, Events & Marketing Director, ISSCA
Registration and program details: issca.com/events/issca-124
About ISSCA
The International Society for Stem Cell Application (ISSCA) is an academic institution and global community advancing the responsible clinical application of regenerative medicine through education, international certification, and hands-on training. Founded in 2010, ISSCA has certified more than 10,000 physicians across 30+ countries. ISSCA teaches and certifies; it does not treat patients. Certificates are issued to physicians (MD) only. ISSCA is operated by Global Stem Cells Group, Inc., 9100 S Dadeland Blvd, Miami, FL 33156.
Media contact: ISSCA Team · info@issca.com · +1 (754) 799-4946
